SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Symbiox Investment & Trading Co Ltd (539278) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 539278 NSE: | Trading | Small Cap

Symbiox Inv.& Tradig Share Price

2 0.18 (9.89%)
As on 10-Apr'26 16:59

Symbiox Investment & Trading Co Ltd (539278)

BSE: 539278 NSE:
Key Metrics
Market Cap
₹6 Cr.
P/E Ratio
0.00
Price to Book (P/B)
0.20
Price to Sales (P/S)
3.10
EV/EBITDA
-28.39
Return on Capital Employed (ROCE)
0.82%
Current Price
₹2
Return on Equity (ROE)
0.61%
Return on Assets (ROA)
0.60%
Operating Profit Margin
9.3%
Net Profit Margin
6.94%
Gross Profit Margin
9.5%
Book Value per Share
₹10.2
Sales Growth (YoY)
-29.23%
Sales Growth (3 Years)
14.68%
Operating Profit Growth (1 Year)
1200%
Operating Profit Growth (3 Years)
15.21%
Net Profit Growth (1 Year)
-9.52%
52-Week Low / High
₹1 / 4
Net Profit Growth (3 Years)
11.38%
Dividend Yield
0.00%
Promoter Holding
3.33%
Pledged shares (%)
of Promoter's holding (%)
0.00%

Check Before You Invest

Q.1
Symbiox Investment & Trading Co Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.
Q.1 Gross Profit margin of Symbiox Investment & Trading Co Ltd?
Symbiox Investment & Trading Co Ltd Gross profit margin which is the profit after deduction of direct costs, is 9.5% for FY-2025 , which is above its 5 year median of 0% , indicating increasing margins.
Q.1 Promoter shareholding and pledge status of Symbiox Investment & Trading Co Ltd?
Promoters hold 3.33% of the Symbiox Investment & Trading Co Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Revenue growth of Symbiox Investment & Trading Co Ltd vs industry peers?
Symbiox Investment & Trading Co Ltd revenue CAGR is 21.56% , compared to the industry median CAGR of 17.75% , indicating faster growth and gaining its market share.
Q.1 Stock return of Symbiox Investment & Trading Co Ltd over the last decade?
Over the last 9 years, the stock has delivered a CAGR of -22.7% based on the current price.
Q.1 Is Symbiox Investment & Trading Co Ltd a good quality company?
Symbiox Investment & Trading Co Ltd is a quality company, based on a 10 year financial track record .

DeciZen - make an informed investing decision on Symbiox Inv.& Tradig

Based on:

M-Cap below 100cr DeciZen not available

Symbiox Investment & Trading Co stock performance

Key Ratios
mw4me loader

Is Symbiox Investment & Trading Co Ltd an attractive stock to invest in?

1. Is Symbiox Investment & Trading Co Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Symbiox Investment & Trading Co Ltd is a below average quality company.

2. Is Symbiox Investment & Trading Co Ltd undervalued or overvalued?

The key valuation ratios of Symbiox Investment & Trading Co Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Symbiox Investment & Trading Co Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Symbiox Investment & Trading Co Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Symbiox Investment & Trading Co Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 0.2%0.5%0.6%0.1%0.1%0.3%0.6%0.7%0.8%0.8%-
Value Creation
Index
-1.0-1.0-1.0-1.0-1.0-1.0-1.0-1.0-0.9-0.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0.621.90.912.11.843.92.82
Sales YoY Gr.-220.6%-7.9%-51.6%15.6%100%-12%117.5%-2%-29.2%-
Adj EPS 000-00000.10.10.1-0.1
YoY Gr.-300%0%-100%NA100%100%25%40%-14.3%-
BVPS (₹) 9.89.89.99.99.99.9101010.110.110.2
Adj Net
Profit
00.10.1-000.10.10.20.20.2-0
Cash Flow from Ops. -17.21.50.51.40.31.1-0.4-4.5-3.13.6-
Debt/CF from Ops. -00.20.60.2100000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 17.8%21.6%14.7%-29.2%
Adj EPS 22%43.1%14.5%-14.3%
BVPS0.4%0.5%0.6%0.6%
Share Price -22.7% 15.3% -20.5% -36.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
0.10.40.4-00.10.20.50.50.70.6-0.5
Op. Profit
Mgn %
-218.9-63.3-46.3-90.8-89.4-449.650.59.4-10.8
Net Profit
Mgn %
6.45.67.1-0.92.33.37.645.36.9-7.8
Debt to
Equity
0000000000-
Working Cap
Days
5,2703,1493,3776,9995,6732,6552,9271,5451,9302,6353,671
Cash Conv.
Cycle
6-1062166-100-183-262-9-25843,661

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 14.68%

Return on Equity is Poor

Sales growth is not so good in last 4 quarters at -22.44%

Latest Financials

Standalone Consolidated
TTM EPS (₹) -0.1 -
TTM Sales (₹ Cr.) 2 -
BVPS (₹) 10.2 -
Reserves (₹ Cr.) 1 -
P/BV 0.20 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 1.36 / 3.77
All Time Low / High (₹) 0.19 / 26.20
Market Cap (₹ Cr.) 6.3
Equity (₹ Cr.) 31.3
Face Value (₹) 10
Industry PE 24.2

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Symbiox Inv.& Tradig - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales0.632.021.860.901.042.081.833.983.902.76
Operating Expenses + 2.013.302.711.711.972.991.663.783.882.51
Manufacturing Costs0000000000
Material Costs1.813.022.351.441.542.531.093.233.472.11
Employee Cost 0.100.110.110.150.130.150.160.190.180.15
Other Costs 0.110.180.250.120.290.310.400.360.220.24
Operating Profit -1.38-1.28-0.86-0.82-0.93-0.910.170.200.020.26
Operating Profit Margin (%) -218.0%-63.3%-46.3%-90.9%-89.3%-44.0%9.6%5.0%0.5%9.3%
Other Income + 1.441.451.040.850.961.010.010.020.230
Exceptional Items 0000000000
Interest 0000000000
Depreciation 0000000000
Profit Before Tax 0.060.160.180.040.030.090.190.220.250.26
Tax 0.020.050.050.050.010.020.050.060.040.07
Profit After Tax 0.040.110.13-0.010.020.070.140.160.210.19
PAT Margin (%) 6.4%5.6%7.1%-1.0%2.3%3.3%7.6%4.0%5.3%6.9%
Adjusted EPS (₹)0.00.00.00.00.00.00.00.10.10.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 30.6030.7130.8430.8730.8930.9631.1731.3231.5331.72
Share Capital 31.2931.2931.2931.2931.2931.2931.2931.2931.2931.29
Reserves -0.69-0.58-0.45-0.42-0.39-0.33-0.120.040.240.44
Debt +0.260.260.260.260.2600000
Long Term Debt0.260.260.260.260.2600000
Short Term Debt0000000000
Minority Interest0000000000
Trade Payables00.721.122.560.702.200.601.330.200.15
Others Liabilities 0.190.220.230.210.150.120.140.160.160.13
Total Liabilities 31.0531.9132.4533.9032.0133.2831.9032.8131.8932.01

Fixed Assets

Net Fixed Assets +0.010.010000000.020.02
Gross Block0.010.010.010.010.010.010.010.010.030.03
Accumulated Depreciation00.010.010.010.010.010.010.010.010.01
CWIP 0000000000
Investments 13.2114.6015.0116.5616.9417.9417.5412.729.8812.71
Inventories0.010.010.0100000.210.091.30
Trade Receivables00.331.601.26000.870.800.020.16
Cash Equivalents 0.080.180.250.120.010.150.190.540.311.06
Others Assets 17.7416.7915.5815.9515.0515.1913.3018.5421.5816.76
Total Assets 31.0531.9132.4533.9032.0133.2831.9032.8131.8932.01

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + -17.211.490.481.430.271.14-0.35-4.47-3.063.58
PBT 0.060.160.180.040.030.090.190.220.250.26
Adjustment 0000000-000
Changes in Working Capital -17.211.330.291.490.261.07-0.51-4.64-3.253.36
Tax Paid -0.0600-0.10-0.02-0.03-0.02-0.05-0.06-0.04
Cash Flow From Investing Activity + 16.84-1.39-0.41-1.55-0.38-10.404.822.83-2.84
Capex -0.01-0.01000000-0.010
Net Investments 16.85-1.38-0.41-1.55-0.38-10.404.822.84-2.84
Others -00000000-00
Cash Flow From Financing Activity + 0000000000
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 0000000000
Net Cash Flow -0.370.100.06-0.12-0.110.140.040.35-0.230.75

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)0.130.370.43-0.030.080.220.450.510.660.61
ROCE (%)0.190.530.570.120.10.30.60.690.790.82
Asset Turnover Ratio0.020.060.060.030.030.060.060.120.120.09
PAT to CFO Conversion(x)-430.2513.553.69N/A13.516.29-2.5-27.94-14.5718.84
Working Capital Days
Receivable Days0591905820087763811
Inventory Days6220000191492
Payable Days0441434683862094661098031

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Symbiox Investment & Trading Co Ltd FAQs

The current trading price of Symbiox Inv.& Tradig on 10-Apr-2026 16:59 is ₹2.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 09-Apr-2026 the market cap of Symbiox Inv.& Tradig stood at ₹6.26 Cr

The latest P/E ratio of Symbiox Inv.& Tradig as of 09-Apr-2026 is 0.00.

The latest P/B ratio of Symbiox Inv.& Tradig as of 09-Apr-2026 is 0.20.

The 52-week high of Symbiox Inv.& Tradig is ₹3.77 and the 52-week low is ₹1.36.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Symbiox Inv.& Tradig is ₹2.02 ( Cr.) .

About Symbiox Investment & Trading Co Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×